These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26774535)

  • 1. The influence of age and approaching death on the course of nondopaminergic symptoms in Parkinson's disease.
    van Rooden SM; Verbaan D; Stijnen T; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2016 Mar; 24():113-8. PubMed ID: 26774535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features associated with the development of non-motor manifestations in Parkinson's disease.
    Juri C; Viviani P; Chaná P
    Arq Neuropsiquiatr; 2008 Mar; 66(1):22-5. PubMed ID: 18392408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early phenotypic differences between Parkinson's disease patients with and without freezing of gait.
    Hall JM; Shine JM; Walton CC; Gilat M; Kamsma YP; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):604-7. PubMed ID: 24679901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premotor and nonmotor features of Parkinson's disease.
    Goldman JG; Postuma R
    Curr Opin Neurol; 2014 Aug; 27(4):434-41. PubMed ID: 24978368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic and cognitive functions in Parkinson's disease (PD).
    Oh ES; Lee JH; Seo JG; Sohn EH; Lee AY
    Arch Gerontol Geriatr; 2011; 52(1):84-8. PubMed ID: 20223528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson's disease.
    Bolitho SJ; Naismith SL; Salahuddin P; Terpening Z; Grunstein RR; Lewis SJ
    PLoS One; 2013; 8(11):e81233. PubMed ID: 24278399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.
    Cubo E; Martín PM; Martin-Gonzalez JA; Rodríguez-Blázquez C; Kulisevsky J;
    Mov Disord; 2010 Jan; 25(1):70-5. PubMed ID: 20014110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive model of health-related quality of life in Parkinson's disease.
    Visser M; van Rooden SM; Verbaan D; Marinus J; Stiggelbout AM; van Hilten JJ
    J Neurol; 2008 Oct; 255(10):1580-7. PubMed ID: 18821041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBA-associated PD presents with nonmotor characteristics.
    Brockmann K; Srulijes K; Hauser AK; Schulte C; Csoti I; Gasser T; Berg D
    Neurology; 2011 Jul; 77(3):276-80. PubMed ID: 21734182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted hypothalamic functional connectivity in patients with PD and autonomic dysfunction.
    Dayan E; Sklerov M; Browner N
    Neurology; 2018 Jun; 90(23):e2051-e2058. PubMed ID: 29728527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment.
    Papapetropoulos S; Ellul J; Polychronopoulos P; Chroni E
    Eur J Neurol; 2004 May; 11(5):347-51. PubMed ID: 15142230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmotor Signs in Genetic Forms of Parkinson's Disease.
    Kasten M; Marras C; Klein C
    Int Rev Neurobiol; 2017; 133():129-178. PubMed ID: 28802919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.
    Wang G; Li XJ; Hu YS; Cheng Q; Wang CF; Xiao Q; Liu J; Ma JF; Zhou HY; Pan J; Tan YY; Wang Y; Chen SD
    Can J Neurol Sci; 2015 Jul; 42(4):242-7. PubMed ID: 26153040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of Nonmotor Symptoms of Parkinson's Disease.
    Jellinger KA
    Int Rev Neurobiol; 2017; 133():13-62. PubMed ID: 28802920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Nonmotor Symptoms in Parkinson's Disease.
    Sauerbier A; Cova I; Rosa-Grilo M; Taddei RN; Mischley LK; Chaudhuri KR
    Int Rev Neurobiol; 2017; 132():361-379. PubMed ID: 28554415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported autonomic symptoms in Parkinson disease.
    Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; van Hilten JJ
    Neurology; 2007 Jul; 69(4):333-41. PubMed ID: 17646625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.